Preemptive liver transplantation in a child with familial hypercholesterolemia

Pediatric Transplantation

Volumn 15, Issue 2, 2011, Pages

  Maiorana, Arianna ^a   Nobili, Valerio ^a   Calandra, Sebastiano ^b   Francalanci, Paola ^a   Bernabei, Silvia ^a   El Hachem, Maya ^a   Monti, Lidia ^a   Gennari, Fabrizio ^a   Torre, Giuliano ^a   De Ville De Goyet, Jean ^a   Bartuli, Andrea ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

cardiovascular risk; familial hypercholesterolemia; LDL cholesterol; LDL apheresis; liver transplantation

Indexed keywords

ATORVASTATIN; BASILIXIMAB; DNA; EZETIMIBE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; STEROID; TACROLIMUS;

ARTICLE; BYPASS SURGERY; CASE REPORT; CHILD; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FRAMESHIFT MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LOW FAT DIET; MONOTHERAPY; PLASMAPHERESIS; PREEMPTIVE LIVER TRANSPLANTATION; PRESCHOOL CHILD; STEROID THERAPY; STOP CODON; XANTHOMATOSIS;

BIOPSY, NEEDLE; BLOOD COMPONENT REMOVAL; CHILD, PRESCHOOL; CHOLESTEROL, LDL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; IMMUNOHISTOCHEMISTRY; LIVER TRANSPLANTATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; XANTHOMATOSIS;

EID: 79951701629     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01383.x     Document Type: Article

References (24)

1. Goldstein JL, Hobbs HH, Brown MS, Goldstein JL, Hobbs HH, Brown MS,. Familial hypercholesterolemia. In:, Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York, NY: McGraw-Hill, 2001: pp. 2863-2913.
2. Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 2006: 114: 2710-2738.
3. Rader DJ, Cohen J, Hobbs HH,. Monogenic hypercholesterolemia: New insights in pathogenesis and treatment. J Clin Invest 2003: 111: 1795-1803. (Pubitemid 38057721)
4. Barth JA, Deckelbaum RJ, Starc TJ, Shea S, Mosca L, Berglund L,. Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: Relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels. J Lab Clin Med 1999: 133: 237-244. (Pubitemid 29112085)
5. Hoeg JM,. Familial hypercholesterolemia. What the zebra can teach us about the horse. JAMA 1994: 271: 543-546. (Pubitemid 24050320)
6. Thompson GR,. LDL apheresis. Atherosclerosis 2003: 167: 1-13. (Pubitemid 36258395)
7. Sachais BS, Katz J, Ross J, Rader DJ,. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia. J Clin Apher 2005: 20: 252-255.
8. Naoumova RP, Thompson GR, Soutar AK,. Current management of severe homozygous hypercholesterolaemias. Curr Opin Lipidol 2004: 15: 413-422. (Pubitemid 39061621)
9. Awan Z, Alrasadi K, Francis GA, et al. Vascular calcifications in homozygote familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2008: 28: 777-785. (Pubitemid 351651345)
10. Kakaei F, Nikeghbalian S, Kazemi K, et al. Liver transplantation for homozygous familial hypercholesterolemia: Two case reports. Transplant Proc 2009: 41: 2939-2941.
11. Schmidt HH, Tietge UJ, Buettner J, et al. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation. Clin Transplant 2008: 22: 180-184. (Pubitemid 351420011)
12. Saito S, Usui A, Akita T, Ueda Y,. Surgery for calcific aortic root stenosis in homozygous familial hypercholesterolemia. Eur J Cardiothorac Surg 2006: 29: 114-116. (Pubitemid 41831363)
13. Kamath BM, Olthoff KM,. Liver transplantation in children: Update 2010. Pediatr Clin North Am 2010: 57: 401-414.
14. Bertolini S, Cantafora A, Averna M, et al. Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol 2000: 20: E41-E52.
15. Raal FJ, Santos RD, Blom DJ, et al. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: A randomised, double-blind, placebo-controlled trial. Lancet 2010: 20: 375.
16. Cuchel M, Bloedon LT, Szapary PO, et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N Engl J Med 2007: 356: 148-156. (Pubitemid 46089675)
17. Starzl TE, Bilheimer DW, Bahnson HT, et al. Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984: 1: 1382-1383. (Pubitemid 14122021)
18. Moini M, Mistry P, Schilsky ML,. Liver transplantation for inherited metabolic disorders of the liver. Curr Opin Organ Transplant 2010: 15: 269-276.
19. Kawagishi N, Satoh K, Akamatsu Y, et al. Long-term outcome after living donor liver transplantation for two cases of homozygous familial hypercholesterolemia from heterozygous donor. J Atheroscler Thromb 2007: 14: 94-98.
20. Shirahata Y, Ohkohchi N, Kawagishi N, et al. Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia. Transpl Int 2003: 16: 276-279. (Pubitemid 36682186)
21. Khalifeh M, Faraj W, Heaton N, Rela M, Sharara AI,. Successful living-related liver transplantation for familial hypercholesterolemia in the Middle East. Transpl Int 2005: 17: 735-739. (Pubitemid 40558234)
22. Castilla Cabezas JA, López-Cillero P, Jiménez J, et al. Role of orthotopic liver transplant in the treatment of homozygous familial hypercholesterolemia. Rev Esp Enferm Dig 2000: 92: 601-608.
23. Moyle M, Tate B,. Homozygous familial hypercholesterolaemia presenting with cutaneous xanthomas: Response to liver transplantation. Australas J Dermatol 2004: 45: 226-228. (Pubitemid 39487040)
24. Thompson GR, Barbir M, Davies D, et al. Efficacy criteria and cholesterol targets for LDL apheresis. Atherosclerosis 2010: 208: 317-321.